Production_NN of_IN Human_NP Papillomavirus_NP Type_NP 16_CD Virus-Like_JJ Particles_NNS in_IN Transgenic_NP Plants_NP Cervical_NP cancer_NN is_VBZ linked_VBN to_TO infection_NN with_IN human_JJ papillomaviruses_NNS (_( HPV_NP )_) and_CC is_VBZ the_DT third_JJ most_RBS common_JJ cancer_NN among_IN women_NNS worldwide_RB ._SENT There_EX is_VBZ a_DT strong_JJ demand_NN for_IN the_DT development_NN of_IN an_DT HPV_NP preventive_JJ vaccine_NN ._SENT Transgenic_NP plants_NNS expressing_VBG the_DT HPV_NP major_JJ capsid_NN protein_NN L1_NP could_MD be_VB a_DT system_NN to_TO produce_VB virus-like_JJ particles_NNS for_IN prophylactic_JJ vaccination_NN or_CC could_MD even_RB be_VB used_VBN as_IN edible_JJ vaccines_NNS to_TO induce_VB an_DT L1-specific_JJ prophylactic_JJ immune_JJ response_NN ._SENT Here_RB ,_, we_PP describe_VBP the_DT generation_NN of_IN transgenic_JJ tobacco_NN and_CC potato_NN plants_NNS carrying_VBG the_DT HPV_NP type_NN 16_CD major_JJ structural_JJ gene_NN L1_NP under_IN the_DT control_NN of_IN the_DT cauliflower_NN mosaic_NN virus_NN 35S_JJ promoter_NN ._SENT All_DT attempts_NNS to_TO express_VB either_RB the_DT original_JJ ,_, unmodified_JJ L1_JJ gene_NN or_CC an_DT L1_JJ gene_NN with_IN a_DT codon_NN usage_NN optimized_VBN for_IN expression_NN in_IN plants_NNS failed_VBD ._SENT Surprisingly_RB ,_, small_JJ amounts_NNS of_IN the_DT protein_NN were_VBD detected_VBN using_VBG an_DT L1_JJ gene_NN optimized_VBN for_IN expression_NN in_IN human_JJ cells_NNS ._SENT However_RB ,_, Northern_JJ blot_NN analysis_NN revealed_VBD that_IN most_JJS of_IN the_DT L1_NP transcripts_NNS were_VBD degraded_VBN ._SENT Introduction_NN of_IN the_DT translational_JJ enhancer_NN Omega_NP derived_VBN from_IN the_DT tobacco_NN mosaic_NN virus_NN strongly_RB increased_VBD transcript_NN stability_NN and_CC resulted_VBD in_IN accumulation_NN of_IN L1_JJ protein_NN to_TO approximately_RB 0.5_CD to_TO 0.2_CD %_NN of_IN total_JJ soluble_JJ protein_NN in_IN transgenic_JJ tobacco_NN and_CC potato_NN plants_NNS ,_, respectively_RB ._SENT The_DT plant-derived_JJ L1_NP protein_NN displayed_VBD conformation-specific_JJ epitopes_NNS and_CC assembled_VBN into_IN virus-like_JJ particles_NNS ._SENT Furthermore_RB ,_, we_PP did_VBD not_RB find_VB any_DT indications_NNS of_IN protein_NN modification_NN of_IN the_DT L1_JJ protein_NN produced_VBN in_IN plants_NNS ._SENT Plant-derived_NP L1_NP was_VBD as_RB immunogenic_JJ as_IN L1_NP expressed_VBD in_IN baculovirus-infected_JJ insect_NN cells_NNS ._SENT Feeding_VBG of_IN tubers_NNS from_IN transgenic_JJ potatoes_NNS to_TO mice_NNS induced_VBN an_DT anti-L1_JJ antibody_NN response_NN in_IN 3_CD out_RB of_IN 24_CD mice_NNS ,_, although_IN this_DT response_NN was_VBD only_RB transient_JJ in_IN two_CD of_IN the_DT mice_NNS ._SENT Our_PP$ data_NNS ,_, however_RB ,_, indicate_VBP that_IN an_DT anti-L1_JJ response_NN was_VBD primed_VBN in_IN about_RB half_JJ of_IN the_DT 24_CD animals_NNS ._SENT The_DT human_JJ papillomaviruses_NNS (_( HPV_NP )_) comprise_VBP a_DT heterogeneous_JJ group_NN of_IN more_JJR than_IN 80_CD epitheliotropic_JJ genotypes_NNS ._SENT The_DT clear_JJ link_NN between_IN infection_NN with_IN "_`` high-risk_JJ "_'' HPV_NP types_NNS and_CC the_DT development_NN of_IN malignant_JJ diseases_NNS was_VBD established_VBN in_IN numerous_JJ epidemiological_JJ and_CC molecular_JJ studies_NNS (_( for_IN reviews_NNS ,_, see_VBP references_NNS ,_, ,_, and_CC )_) ._SENT Worldwide_NP ,_, HPV_NP are_VBP responsible_JJ for_IN approximately_RB half_PDT a_DT million_CD new_JJ cervical_JJ cancer_NN cases_NNS every_DT year_NN ,_, as_IN HPV_NP DNA_NP of_IN high-risk_JJ genotypes_NNS can_MD be_VB found_VBN in_IN more_JJR than_IN 95_CD %_NN of_IN these_DT cancers_NNS ._SENT About_IN half_NN of_IN these_DT cases_NNS are_VBP associated_VBN with_IN infections_NNS with_IN HPV_NP type_NN 16_CD (_( HPV-16_NP )_) ._SENT Despite_IN improved_VBN abilities_NNS to_TO detect_VB and_CC cure_VB premalignant_JJ lesions_NNS ,_, a_DT high_JJ percentage_NN of_IN patients_NNS still_RB develops_VBZ persistent_JJ or_CC metastatic_JJ disease_NN for_IN which_WDT no_DT effective_JJ therapy_NN is_VBZ available_JJ ._SENT Therefore_RB ,_, there_EX is_VBZ urgent_JJ need_NN to_TO develop_VB a_DT prophylactic_JJ subviral_JJ vaccine_NN for_IN preventing_VBG infection_NN with_IN HPV_NP and_CC thereby_RB ,_, most_RBS likely_RB ,_, the_DT development_NN of_IN cervical_JJ cancer_NN ._SENT The_DT fact_NN that_IN for_IN a_DT long_JJ time_NN it_PP was_VBD not_RB possible_JJ to_TO produce_VB papillomaviruses_NNS under_IN cell_NN culture_NN conditions_NNS has_VBZ hindered_VBN the_DT development_NN of_IN a_DT capsid-directed_JJ vaccine_NN ,_, e.g._FW ,_, inactivated_VBN virions_NNS ._SENT About_IN a_DT decade_NN ago_RB ,_, it_PP was_VBD demonstrated_VBN that_DT expression_NN of_IN the_DT papillomavirus_NN major_JJ capsid_NN gene_NN L1_NP alone_RB ,_, or_CC together_RB with_IN the_DT minor_JJ capsid_NN protein_NN L2_NP ,_, is_VBZ sufficient_JJ for_IN the_DT generation_NN of_IN virus-like_JJ particles_NNS (_( VLPs_NP )_) ._SENT Subsequently_RB ,_, VLP_NP production_NN was_VBD shown_VBN for_IN virtually_RB all_DT experimental_JJ systems_NNS ,_, such_JJ as_IN mammalian_JJ cells_NNS ,_, baculovirus-infected_JJ insect_NN cells_NNS ,_, yeasts_NNS ,_, and_CC Escherichia_NP coli_NNS as_RB well_RB as_IN in_IN cell-free_JJ systems_NNS ._SENT VLPs_NNS mimic_VBP in_IN some_DT aspects_NNS the_DT infection_NN with_IN virions_NNS and_CC induce_VB virus-neutralizing_JJ antibodies_NNS ._SENT Thus_RB ,_, VLPs_NP became_VBD the_DT most_RBS attractive_JJ candidate_NN for_IN developing_VBG a_DT prophylactic_JJ vaccine_NN against_IN HPV_NP infections_NNS ._SENT Papillomavirus_NP VLPs_NP are_VBP very_RB efficient_JJ in_IN inducing_VBG both_DT humoral_JJ and_CC cellular_JJ immune_JJ responses_NNS ._SENT VLP-induced_JJ antibodies_NNS provided_VBD protective_JJ immunity_NN against_IN challenge_NN with_IN infectious_JJ viruses_NNS in_IN animal_JJ models_NNS ._SENT In_IN addition_NN to_TO the_DT induction_NN of_IN a_DT prophylactic_JJ immune_JJ response_NN ,_, papillomavirus_NP VLPs_NP bind_NN to_TO and_CC lead_VB to_TO the_DT activation_NN of_IN dendritic_JJ cells_NNS in_IN vitro_NN ._SENT The_DT potential_NN of_IN VLPs_NP as_IN prophylactic_JJ vaccines_NNS is_VBZ currently_RB being_VBG assessed_VBN in_IN a_DT number_NN of_IN different_JJ clinical_JJ trials_NNS ._SENT In_IN fact_NN ,_, a_DT recent_JJ report_NN demonstrated_VBD that_DT administration_NN of_IN HPV-16_NP VLPs_NP significantly_RB lowers_VBZ infection_NN with_IN HPV-16_NP and_CC leads_VBZ to_TO a_DT reduction_NN HPV-16-associated_JJ disease_NN ._SENT Cervical_JJ cytology_NN screening_NN has_VBZ resulted_VBN in_IN a_DT significant_JJ decline_NN in_IN mortality_NN from_IN cervical_JJ cancer_NN in_IN highly_RB developed_VBN countries_NNS ,_, but_CC cervical_JJ cancer_NN remains_VBZ one_CD of_IN the_DT main_JJ causes_NNS of_IN cancer-related_JJ death_NN in_IN most_JJS of_IN the_DT less_RBR well_RB developed_VBN countries_NNS ._SENT However_RB ,_, costly_JJ production_NN and_CC distribution_NN of_IN current_JJ VLP_NP vaccines_NNS ,_, e.g._FW ,_, by_IN the_DT use_NN of_IN recombinant_JJ baculoviruses_NNS ,_, will_MD prevent_VB their_PP$ widespread_JJ application_NN in_IN less_JJR developed_JJ countries_NNS ._SENT Many_JJ biopharmaceuticals_NNS are_VBP traditionally_RB produced_VBN using_VBG a_DT variety_NN of_IN transgenic_JJ systems_NNS including_VBG mammalian_JJ cells_NNS or_CC insect_NN tissue_NN cultures_NNS ;_: however_RB ,_, in_IN these_DT expression_NN systems_NNS it_PP is_VBZ usually_RB difficult_JJ and_CC costly_JJ to_TO control_VB GMP_NP production_NN ._SENT Transgenic_NP plants_NNS have_VBP been_VBN evaluated_VBN as_IN an_DT alternative_JJ expression_NN system_NN for_IN vaccines_NNS and_CC other_JJ therapeutic_JJ proteins_NNS and_CC have_VBP several_JJ economic_JJ and_CC qualitative_JJ benefits_NNS ._SENT Expression_NN of_IN vaccines_NNS in_IN plants_NNS eliminates_VBZ the_DT risk_NN of_IN contamination_NN with_IN animal_JJ pathogens_NNS ,_, provides_VBZ a_DT heat-stable_JJ environment_NN ,_, and_CC would_MD ,_, if_IN administered_VBN as_IN an_DT edible_JJ vaccine_NN ,_, avoid_VB injection-related_JJ hazards_NNS ._SENT Apart_RB from_IN these_DT advantages_NNS ,_, plants_NNS can_MD be_VB grown_VBN on_IN a_DT large_JJ scale_NN ,_, and_CC existing_VBG cultivation_NN ,_, harvest_NN ,_, and_CC storage_NN facilities_NNS can_MD be_VB utilized_VBN ._SENT Within_IN the_DT last_JJ years_NNS a_DT number_NN of_IN vaccines_NNS have_VBP been_VBN successfully_RB expressed_VBN in_IN plants_NNS and_CC orally_RB delivered_VBN to_TO animals_NNS to_TO determine_VB their_PP$ immunogenicity_NN ,_, such_JJ as_IN the_DT Norwalk_NP virus_NN capsid_NN protein_NN ,_, the_DT hepatitis_NP B_NP surface_NN antigen_NN ,_, and_CC the_DT heat-labile_JJ nontoxic_JJ subunit_NN B_NN of_IN the_DT E._NP coli_NNS enterotoxin_NN ._SENT Recently_RB ,_, it_PP has_VBZ been_VBN shown_VBN that_IN oral_JJ application_NN of_IN HPV-16_NP VLPs_NP leads_VBZ to_TO the_DT induction_NN of_IN capsid-specific_JJ antibodies_NNS in_IN mice_NNS ,_, indicating_VBG that_IN oral_JJ vaccination_NN against_IN papillomaviruses_NNS is_VBZ a_DT serious_JJ option_NN ._SENT Here_RB ,_, we_PP describe_VBP the_DT development_NN of_IN a_DT plant_NN expression_NN system_NN to_TO produce_VB the_DT HPV-16_NP L1_NP structural_JJ protein_NN and_CC demonstrate_VB its_PP$ functionality_NN for_IN vaccination_NN purposes_NNS ._SENT Plant_NN material_NN and_CC growth_NN conditions_NNS ._SENT |_SYM Tobacco_NP plants_NNS (_( Nicotiana_NP tabacum_NN cv_NN ._SENT Samsun_NP NN_NP )_) and_CC potato_NN plants_NNS (_( Solanum_NP tuberosum_NN cv_NN ._SENT Solara_NP )_) were_VBD grown_VBN in_IN tissue_NN culture_NN under_IN regimens_NNS of_IN 16_CD h_NN of_IN light_NN ,_, 8_CD h_NN of_IN darkness_NN on_IN Murashige_NP Skoog_NP medium_NN containing_VBG 2_CD %_NN (_( wt/vol_NN )_) sucrose_NN ._SENT After_IN initial_JJ characterization_NN of_IN in_IN vitro-grown_JJ plants_NNS ,_, tobacco_NN and_CC potato_NN plants_NNS were_VBD transferred_VBN to_TO the_DT greenhouse_NN ._SENT Plants_NNS were_VBD cultivated_VBN in_IN soil_NN with_IN 16_CD h_NN of_IN supplemental_JJ light_NN (_( ca_MD ._SENT 250_CD mumol_NN quanta_NNS photosynthetic_JJ active_JJ radiation_NN m-2_NN s-1_NN )_) followed_VBN by_IN 8_CD h_NN darkness_NN ._SENT The_DT temperature_NN regimen_NN followed_VBD a_DT day-night_JJ cycle_NN with_IN 25_CD and_CC 20C_JJ for_IN tobacco_NN and_CC 22_CD and_CC 18C_NP for_IN potato_NN plants_NNS ._SENT Plasmid_NP construction_NN ._SENT |_SYM To_TO produce_VB L1_JJ transgenic_JJ plants_NNS ,_, the_DT unmodified_JJ and_CC the_DT codon-optimized_JJ HPV-16_NP L1_NP genes_NNS (_( L1ori_NP ,_, L1p_NP ,_, and_CC L1h_NP )_) were_VBD excised_VBN from_IN the_DT cloning_VBG vector_NN pBK-CMV_NP (_( Stratagene_NP )_) using_VBG the_DT SalI/KpnI_NP restriction_NN sites_NNS and_CC inserted_VBN into_IN a_DT Bin-19-derived_JJ binary_JJ vector_NN containing_VBG the_DT constitutive_JJ Cauliflower_NP mosaic_NN virus_NN (_( CaMV_NP )_) 35S_JJ promoter_NN and_CC the_DT octopine_JJ synthase_NN polyadenylation_NN signal_NN ._SENT L1p_NP and_CC L1h_NP display_VBP a_DT codon_NN composition_NN adapted_VBD to_TO the_DT codon_NN usage_NN database_NN shown_VBN in_IN table_NN format_NN for_IN S._NP tuberosum_NP and_CC Homo_NP sapiens_JJ in_IN reference_NN ,_, respectively_RB ._SENT Both_DT sequences_NNS are_VBP available_JJ from_IN the_DT EMBL_NP database_NN under_IN the_DT accession_NN numbers_NNS and_CC ._SENT In_IN the_DT OD-L1h_NP construct_NN ,_, the_DT TMV-U1_JJ translational_JJ enhancer_NN element_NN (_( Omega_NP )_) was_VBD fused_VBN upstream_RB of_IN the_DT L1_JJ initiation_NN codon_NN ._SENT To_TO allow_VB the_DT insertion_NN of_IN the_DT enhancer_NN element_NN ,_, a_DT novel_JJ NcoI_NP restriction_NN site_NN was_VBD introduced_VBN into_IN the_DT L1_JJ gene_NN ,_, overlapping_VBG with_IN the_DT ATG_NP initiation_NN codon_NN ,_, changing_VBG the_DT second_JJ amino_NN acid_NN of_IN L1_NP into_IN an_DT alanine_NN (_( S2->A_NP )_) ._SENT Plant_NN transformation_NN ._SENT |_SYM The_DT binary_JJ constructs_NNS were_VBD transformed_VBN into_IN Agrobacterium_NN tumefaciens_NNS strain_VBP CV58C1_NP ,_, which_WDT carries_VBZ the_DT virulence_NN plasmid_NN pGV2260_NN ._SENT Transformation_NN of_IN tobacco_NN and_CC potato_NN plants_NNS using_VBG Agrobacterium-mediated_JJ gene_NN transfer_NN was_VBD carried_VBN out_IN according_VBG to_TO Rosahl_NP et_FW al._FW and_CC Rocha-Sosa_NN et_FW al._FW ,_, respectively_RB ._SENT RNA_NP isolation_NN and_CC Northern_JJ blot_NN analysis_NN ._SENT |_SYM Isolation_NN of_IN total_JJ RNA_NP was_VBD performed_VBN as_IN described_VBN by_IN Logemann_NP et_FW al._FW ._SENT Aliquots_NNS (_( 20_CD to_TO 30_CD mug_NN )_) of_IN total_JJ RNA_NP were_VBD separated_VBN on_IN 1.5_CD %_NN formaldehyde-containing_NN agarose_NN gels_NNS and_CC blotted_VBN onto_IN nylon_NN membranes_NNS (_( GeneScreen_NP ;_: NEN_NP ,_, Boston_NP ,_, Mass._NP )_) by_IN capillary_NN blotting_VBG overnight_JJ ._SENT The_DT membranes_NNS were_VBD prehybridized_VBN and_CC hybridized_VBN at_IN 65C_JJ ._SENT Radioactive_JJ labeling_VBG of_IN respective_JJ cDNA_NN fragments_NNS was_VBD performed_VBN with_IN [_SYM alpha-32P]dCTP_NN using_VBG the_DT High_NP Prime_NP kit_NN (_( Boehringer_NP Mannheim_NP ,_, Germany_NP )_) ._SENT After_IN stringent_JJ washing_NN ,_, radioactive_JJ membranes_NNS were_VBD exposed_VBN to_TO X-ray_VB films_NNS (_( Kodak_NP )_) overnight_RB at_IN -70C_NN ._SENT Western_JJ blot_NN analysis_NN ._SENT |_SYM Leaf_NP disks_NNS (_( 0.28_CD cm2_NN )_) or_CC tuber_NN slices_VBZ (_( ca_MD ._SENT 50_CD to_TO 100_CD mg_NN ,_, fresh_JJ weight_NN )_) were_VBD homogenized_VBN in_IN extraction_NN buffer_NN containing_VBG 50_CD mM_NP Tris-HCl_NP (_( pH_NN 6.8_CD )_) ,_, 5_CD mM_NP MgCl2_NP ,_, 1_CD mM_NP EDTA_NP ,_, 1_CD mM_NP EGTA_NP ,_, 5_CD mM_NP beta-mercaptoethanol_NN ,_, 0.2_CD mM_NP Pefabloc_NP proteinase_NN inhibitor_NN ,_, and_CC 15_CD %_NN glycerol_NN ._SENT Samples_NNS were_VBD centrifuged_VBN for_IN 5_CD min_NN at_IN 4C_JJ ,_, and_CC protein_NN content_NN of_IN the_DT supernatant_JJ was_VBD determined_VBN according_VBG to_TO the_DT method_NN in_IN reference_NN ._SENT Sodium_NN dodecyl_NN sulfate_NN (SDS)-containing_NN sample_NN buffer_NN was_VBD added_VBN ,_, and_CC after_IN heat-denaturation_NN 10_CD to_TO 30_CD mug_NN protein_NN was_VBD separated_VBN on_IN SDS-12.5_NP %_NN (_( vol/vol_NN )_) polyacrylamide_NN gels_NNS ._SENT Proteins_NNS were_VBD transferred_VBN onto_IN nitrocellulose_NN membranes_NNS (_( Hybond_NP C_NP ;_: Amersham_NP Pharmacia_NP Biotech_NP ,_, Braunschweig_NP ,_, Germany_NP )_) ,_, blocked_VBN for_IN 1_CD h_NN in_IN 5_CD %_NN skim_NN milk-TBST_NN (_( 20_CD mM_NP Tris_NP ,_, 500_CD mM_NP NaCl_NP ,_, 0.1_CD %_NN [_SYM vol/vol_NN ]_SYM Tween_NP 20_CD )_) and_CC incubated_VBN for_IN a_DT minimum_NN of_IN 2_CD h_NN with_IN rabbit_NN antiserum_NN raised_VBN against_IN insect_NN cell-derived_JJ VLPs_NP ._SENT Immunodetection_NN was_VBD performed_VBN using_VBG the_DT ECL_NN system_NN (_( Amersham_NP Pharmacia_NP Biotech_NP ,_, Braunschweig_NP ,_, Germany_NP )_) according_VBG to_TO the_DT manufacturer_NN 's_POS instruction_NN ._SENT Enzyme-linked_JJ immunosorbent_JJ assay_NN (_( ELISA_NP )_) ._SENT |_SYM For_IN the_DT detection_NN of_IN HPV-16_NP L1-specific_NP antibodies_NNS ,_, microtiter_NN plates_NNS were_VBD coated_VBN overnight_RB with_IN 50_CD mul_NN of_IN phosphate-buffered_JJ saline_NN (_( PBS_NP )_) containing_VBG 35_CD mug_NN of_IN VLPs_NNS derived_VBN from_IN insect_NN cells_NNS per_IN ml_NN ._SENT After_IN blocking_VBG of_IN the_DT plates_NNS (_( in_IN 5_CD %_NN skim_NN milk_NN in_IN PBS_NP for_IN 1_CD h_NN at_IN 37C_JJ )_) ,_, 1:100_CD to_TO 1:12,800_CD dilutions_NNS of_IN mouse_NN sera_NN were_VBD added_VBN and_CC incubated_VBN for_IN 1_CD h_NN at_IN 37C_JJ ._SENT To_TO determine_VB nonspecific_JJ binding_NN ,_, the_DT same_JJ dilutions_NNS of_IN the_DT antisera_NN were_VBD tested_VBN on_IN plates_NNS coated_VBN with_IN PBS_NP only_RB ._SENT After_IN washing_NN ,_, peroxidase-conjugated_JJ goat_NN anti-mouse_NN antibodies_NNS (_( Sigma_NP )_) were_VBD added_VBN at_IN a_DT 1:4,000_CD dilution_NN ._SENT After_IN 1_CD h_NN at_IN 37C_JJ plates_NNS were_VBD washed_VBN and_CC stained_VBN with_IN ABTS_NP (_( 2,2'-azino-bis-3-ethylbenzthiazolin-6-sulfonic_JJ acid_NN )_) substrate_NN solution_NN (_( 1_CD mg/ml_NN ,_, containing_VBG 0.015_CD %_NN H2O2_NN )_) ._SENT Extinction_NN at_IN 405_CD nm_NN was_VBD measured_VBN after_IN 20_CD min_NN in_IN a_DT Titertek_NP automated_JJ plate_NN reader_NN ._SENT To_TO allow_VB relative_JJ quantification_NN of_IN VLPs_NP in_IN CsCl_NP fractions_NNS ,_, we_PP used_VBD an_DT antigen_NN capture_NN ELISA_NP ._SENT Microtiter_NP plates_NNS were_VBD coated_VBN overnight_RB with_IN a_DT 1:500_CD dilution_NN of_IN protein_NN A-purified_JJ mouse_NN monoclonal_NN antibody_NN (_( 50_CD mul/well_NN )_) specific_JJ for_IN HPV-16_NP VLPs_NP (_( final_JJ concentration_NN of_IN 2_CD mug_NN per_IN ml_NN ,_, in_IN PBS_NP )_) ._SENT Plates_NNS were_VBD blocked_VBN with_IN 5_CD %_NN skim_NN milk-PBS_NNS for_IN 1_CD h._NN After_IN adding_VBG 50_CD mul_NN of_IN CsCl_NP fractions_NNS using_VBG 1:5_CD to_TO 1:300_CD dilution_NN (_( in_IN 5_CD %_NN skim_NN milk-PBS_NNS )_) plates_NNS were_VBD kept_VBN for_IN 1_CD h_NN at_IN 37C_JJ ._SENT After_IN three_CD washings_NNS with_IN PBS-0.05_NP %_NN Tween_NP 20_CD ,_, 50_CD mul_NN of_IN a_DT polyclonal_JJ rabbit_NN antiserum_NN (_( 1:3,000_CD dilution_NN in_IN PBS_NP )_) raised_VBD against_IN HPV-16_NP VLPs_NP was_VBD added_VBN ,_, and_CC plates_NNS were_VBD incubated_VBN at_IN 37C_JJ for_IN 1_CD h._NP Plates_NP were_VBD washed_VBN again_RB and_CC further_RBR incubated_VBD with_IN 50_CD mul_NN of_IN a_DT goat-anti-rabbit_JJ peroxidase_NN conjugate_VB (_( 1:5,000_CD in_IN milk-PBS_NNS ;_: Sigma_NP )_) ._SENT After_IN a_DT final_JJ washing_NN step_NN ,_, ABTS_NP substrate_NN was_VBD added_VBN and_CC allowed_VBN to_TO develop_VB for_IN 30_CD min_NN ._SENT Extinction_NN was_VBD measured_VBN at_IN 405_CD nm_NN in_IN a_DT Dynatech_NP automated_JJ plate_NN reader_NN ._SENT Purification_NN of_IN VLPs_NP ._SENT |_SYM TN-High_NP Five_NP cells_NNS were_VBD grown_VBN to_TO a_DT density_NN of_IN 1_CD x_NN 106_CD to_TO 2_CD x_NN 106_CD cells_NNS per_IN ml_NN of_IN Ex-Cell_JJ 405_CD serum-free_JJ medium_NN (_( JRH_NP Biosciences_NP )_) ._SENT About_RB 2_CD x_NN 108_CD cells_NNS were_VBD pelleted_VBN at_IN 1,000_CD x_NN g_NN for_IN 15_CD min_NN ,_, resuspended_VBN in_IN 20_CD ml_NN of_IN medium_NN ,_, and_CC infected_VBN with_IN recombinant_JJ baculoviruses_NNS at_IN an_DT MOI_NP of_IN 2_CD to_TO 5_CD for_IN 1_CD h_NN at_IN room_NN temperature_NN ._SENT Cells_NNS were_VBD further_RBR incubated_VBN in_IN shaker_NN bottles_NNS for_IN 3_CD days_NNS and_CC then_RB harvested_VBN by_IN centrifugation_NN ._SENT Cell_NN pellets_NNS were_VBD resuspended_VBN in_IN extraction_NN buffer_NN ._SENT All_DT following_VBG steps_NNS were_VBD performed_VBN at_IN 4C_JJ ._SENT After_IN sonication_NN for_IN 1_CD min_NN at_IN 60_CD W_NP ,_, the_DT extract_NN was_VBD centrifuged_VBN at_IN 10,000_CD rpm_NN in_IN a_DT Sorvall_NP SS34_NP rotor_NN ._SENT The_DT pellet_NN was_VBD resuspended_VBN in_IN 10_CD ml_NN of_IN extraction_NN buffer_NN ,_, sonicated_VBD again_RB ,_, and_CC centrifuged_VBN ._SENT The_DT combined_JJ supernatants_NNS were_VBD layered_VBN onto_IN a_DT two-step_JJ gradient_NN consisting_VBG of_IN 8_CD ml_NN of_IN 40_CD %_NN sucrose_NN on_IN top_NN of_IN 8_CD ml_NN of_IN CsCl_NP solution_NN and_CC centrifuged_VBN in_IN a_DT Sorvall_NP AH629_NP swinging_VBG bucket_NN rotor_NN for_IN 2_CD h_NN at_IN 27,000_CD rpm_NN (_( 10C_NP )_) ._SENT The_DT interphase_NN between_IN CsCl_NP and_CC sucrose_NN and_CC the_DT complete_JJ layer_NN of_IN CsCl_NP were_VBD collected_VBN and_CC transferred_VBN to_TO 13.4-ml_JJ Quickseal_JJ tubes_NNS (_( Beckman_NP )_) ._SENT Volume_NN was_VBD adjusted_VBN by_IN adding_VBG extraction_NN buffer_NN ,_, and_CC tubes_NNS were_VBD centrifuged_VBN overnight_RB at_IN 50,000_CD rpm_NN at_IN 20C_JJ in_IN a_DT Beckman_NP 70_CD Ti_NP rotor_NN ._SENT One-milliliter_NN fractions_NNS were_VBD collected_VBN ,_, and_CC subsequently_RB 2.5_CD mul_NN of_IN each_DT fraction_NN was_VBD separated_VBN on_IN an_DT SDS-10_NP %_NN polyacrylamide_NN gel_NN and_CC L1_JJ protein_NN was_VBD detected_VBN by_IN Western_NP blotting_VBG ._SENT VLPs_NNS from_IN plant_NN cells_NNS were_VBD extracted_VBN using_VBG a_DT modified_JJ protocol_NN ._SENT Leaf_NN material_NN was_VBD frozen_VBN in_IN liquid_JJ nitrogen_NN and_CC pulverized_VBD using_VBG a_DT mortar_NN and_CC pestle_NN ;_: potato_NN tubers_NNS were_VBD sliced_VBN and_CC mechanically_RB homogenized_VBN ._SENT Five_CD grams_NNS of_IN plant_NN material_NN (_( in_IN 20_CD ml_NN of_IN buffer_NN additionally_RB containing_VBG 1_CD %_NN polyvinyl_NN pyrrolidone_NN to_TO adsorb_VB the_DT phenolic_JJ compounds_NNS )_) was_VBD then_RB subjected_VBN to_TO further_JJR extraction_NN using_VBG a_DT French_JJ press_NN ._SENT Extracts_VBZ were_VBD cleared_VBN by_IN centrifugation_NN ._SENT L1-containing_VBG supernatant_JJ was_VBD sedimented_VBN through_IN a_DT sucrose_NN cushion_NN and_CC further_RBR purified_VBN by_IN CsCl_NP density_NN centrifugation_NN ._SENT Analysis_NN of_IN L1_JJ assembly_NN by_IN sucrose_NN sedimentation_NN ._SENT |_SYM To_TO separate_VB different_JJ assembly_NN forms_NNS of_IN L1_NP ,_, crude_NN extracts_VBZ from_IN tobacco_NN leaves_NNS and_CC potato_NN tubers_NNS were_VBD loaded_VBN onto_IN linear_JJ (_( 5_CD to_TO 50_CD %_NN ,_, wt/vol_NP )_) sucrose_NN gradients_NNS ._SENT Plant_NN material_NN (_( 2.8_CD g_NN )_) was_VBD sliced_VBN and_CC homogenized_VBN in_IN liquid_JJ nitrogen_NN using_VBG a_DT mortar_NN and_CC a_DT pestle_NN ._SENT The_DT material_NN was_VBD resuspended_VBN in_IN 1_CD to_TO 2_CD ml_NN of_IN ice-cold_JJ extraction_NN buffer_NN and_CC sonicated_JJ four_CD times_NNS for_IN 30_CD s_NNS at_IN a_DT low_JJ setting_NN ._SENT The_DT extract_NN was_VBD cleared_VBN by_IN centrifugation_NN at_IN 15,000_CD x_NN g_NN for_IN 15_CD min_NN ._SENT Six_CD hundred_CD microliters_NNS ,_, representing_VBG approximately_RB one-eighth_JJ of_IN the_DT total_JJ extract_NN ,_, was_VBD loaded_VBN on_IN top_NN of_IN a_DT 5-to-50_JJ %_NN linear_JJ sucrose_NN gradient_NN and_CC centrifuged_VBN at_IN 160,000_CD x_NN g_NN for_IN 3_CD h_NN in_IN a_DT Beckman_NP SW41Ti_NP rotor_NN ._SENT Twenty_CD fractions_NNS were_VBD collected_VBN and_CC analyzed_VBN by_IN antigen-capture_NP ELISA_NP and_CC Western_NP blotting_VBG for_IN the_DT presence_NN of_IN L1_JJ protein_NN ._SENT Electron_NP microscopy_NN ._SENT |_SYM Twenty-microliter_NP samples_NNS of_IN the_DT fractions_NNS collected_VBN from_IN the_DT CsCl_NP gradient_NN were_VBD dialyzed_VBN against_IN 10_CD mM_NP HEPES_NP (_( pH_NN 7.5_CD )_) for_IN 45_CD min_NN on_IN floating_VBG filter_NN pads_NNS (_( 0.02-mum_NN pore_NN size_NN ;_: Millipore_NP )_) ._SENT Carbon-coated_JJ copper_NN grids_NNS (_( 200-mesh_JJ size_NN ;_: EM_NP Sciences_NPS )_) were_VBD treated_VBN with_IN 20_CD mul_NN of_IN poly-l-lysine_NN (_( 1_CD mg/ml_NN ;_: Sigma_NP )_) for_IN 2_CD min_NN ._SENT The_DT samples_NNS were_VBD placed_VBN onto_IN the_DT grid_NN and_CC stained_VBN with_IN 30_CD mul_NN of_IN a_DT 2_CD %_NN uranyl_NN acetate_NN solution_NN for_IN 2_CD min_NN ._SENT After_IN air-drying_JJ of_IN the_DT grids_NNS ,_, specimens_NNS were_VBD inspected_VBN with_IN a_DT Zeiss_NP EM_NP 900_CD electron_NN microscope_NN at_IN 80_CD kV_NN ._SENT Immunization_NN of_IN mice_NNS ._SENT |_SYM BALB/c_NP mice_NNS were_VBD immunized_VBN subcutaneously_RB (_( s.c._JJ )_) with_IN 40_CD ng_NNS of_IN CsCl-purified_NP VLPs_NP derived_VBD either_RB from_IN plants_NNS or_CC from_IN insect_NN cells_NNS ._SENT The_DT first_JJ immunization_NN was_VBD performed_VBN using_VBG complete_JJ Freund_NP 's_POS adjuvants_NNS ._SENT After_IN 4_CD and_CC 8_CD weeks_NNS ,_, respectively_RB ,_, two_CD booster_NN immunizations_NNS were_VBD carried_VBN out_IN using_VBG incomplete_JJ Freund_NP 's_POS adjuvants_NNS ._SENT Two_CD weeks_NNS after_IN the_DT third_JJ immunization_NN mice_NNS were_VBD sacrificed_VBN and_CC serum_NN was_VBD collected_VBN ._SENT For_IN oral_JJ immunization_NN ,_, the_DT five_CD different_JJ groups_NNS of_IN mice_NNS were_VBD fed_VBN four_CD times_NNS with_IN 5_CD g_NN of_IN sliced_VBN ,_, raw_JJ potato_NN tubers_NNS per_IN mouse_NN on_IN days_NNS 1_CD ,_, 14_CD ,_, 32_CD ,_, and_CC 46_CD ._SENT Prior_RB to_TO each_DT feeding_NN ,_, the_DT mice_NNS were_VBD starved_VBN for_IN 24_CD h._NNS Each_DT feeding_NN lasted_VBD 20_CD h_NN ,_, and_CC the_DT weight_NN of_IN uneaten_JJ tubers_NNS was_VBD determined_VBN thereafter_RB (_( ranging_VBG between_IN 0_CD and_CC 12_CD %_NN )_) ._SENT Blood_NN samples_NNS were_VBD collected_VBN on_IN days_NNS 0_CD ,_, 12_CD ,_, 30_CD ,_, 44_CD ,_, and_CC 58_CD ._SENT On_IN day_NN 79_CD all_DT mice_NNS received_VBD a_DT subimmunogenic_JJ dose_NN of_IN insect_NN cell-derived_JJ VLPs_NP s.c._NN without_IN adjuvants_NNS ._SENT Final_NP bleeds_VBZ were_VBD collected_VBN on_IN day_NN 79_CD ._SENT In_IN one_CD experimental_JJ and_CC one_CD control_NN group_NN the_DT potato_NN tubers_NNS in_IN each_DT of_IN the_DT feedings_NNS were_VBD spiked_VBN with_IN 10_CD mug_NN of_IN CpG_NP DNA_NP per_IN 5_CD g_NN of_IN tubers_NNS in_IN the_DT from_IN of_IN plasmid_NP DNA_NP (_( with_IN no_DT HPV-specific_JJ sequences_NNS )_) ,_, in_IN one_CD additional_JJ group_NN the_DT transgenic_JJ potatoes_NNS were_VBD spiked_VBN with_IN 10_CD mug_NN of_IN cholera_NN toxin_NN B_NN peptide_NN (_( Sigma_NP )_) per_IN 5_CD g_NN of_IN tubers_NNS ._SENT Optimization_NP of_IN HPV-16_NP L1_NP for_IN expression_NN in_IN plants_NNS ._SENT |_SYM Our_NN aim_NN was_VBD to_TO evaluate_VB transgenic_JJ plants_NNS as_IN a_DT tool_NN to_TO express_VB the_DT major_JJ structural_JJ protein_NN L1_NP of_IN HPV-16_NP in_IN the_DT form_NN of_IN VLPs_NNS suitable_JJ for_IN prophylactic_JJ vaccination_NN purposes_NNS ._SENT To_TO this_DT end_NN ,_, transgenic_JJ plants_NNS were_VBD engineered_VBN using_VBG the_DT Agrobacterium-mediated_JJ transformation_NN system_NN followed_VBN by_IN selection_NN of_IN transgenic_JJ plants_NNS for_IN kanamycin-resistance_NN ._SENT Initially_RB ,_, transgenic_JJ potato_NN plants_NNS were_VBD generated_VBN expressing_VBG the_DT unmodified_JJ HPV-16_NP L1_NP gene_NN (_( L1ori_NP )_) under_IN the_DT control_NN of_IN the_DT CaMV_NP 35S_JJ promoter_NN ._SENT However_RB ,_, the_DT L1_NP protein_NN was_VBD not_RB detectable_JJ in_IN 10_CD to_TO 30_CD mug_NN of_IN plant_NN protein_NN extracts_VBZ in_IN Western_JJ blots_NNS using_VBG an_DT L1-specific_JJ antibody_NN ._SENT This_DT indicates_VBZ that_IN the_DT expression_NN level_NN was_VBD below_IN the_DT detection_NN limit_NN ,_, which_WDT is_VBZ about_RB 5_CD ng_NNS of_IN L1-protein_NP (_( purified_VBN from_IN insect_NN cells_NNS )_) ._SENT In_IN order_NN to_TO achieve_VB L1_JJ expression_NN in_IN plants_NNS ,_, codon_NN composition_NN of_IN the_DT L1_NP gene_NN was_VBD adapted_VBN according_VBG to_TO codon_NN usage_NN tabulated_VBN in_IN reference_NN for_IN S._NP tuberosum_NN (_( 16_CD L1p_NP ;_: EMBL_NP database_NN AJ313181_NP )_) ._SENT Earlier_RBR ,_, we_PP reported_VBD that_IN this_DT gene_NN was_VBD efficiently_RB expressed_VBN in_IN mammalian_JJ cells_NNS via_IN transient-transfection_NN assays_NNS ._SENT A_DT total_NN of_IN 55_CD different_JJ transgenic_JJ tobacco_NN plants_NNS were_VBD obtained_VBN ,_, in_IN which_WDT a_DT CaMV_NP 35S_JJ promoter_NN was_VBD driving_VBG the_DT expression_NN of_IN 16_CD L1p_NP ._SENT Accumulation_NP of_IN L1p_NP in_IN these_DT lines_NNS was_VBD analyzed_VBN by_IN Western_NP blotting_VBG ._SENT However_RB ,_, as_RB before_IN no_DT L1-specific_JJ signal_NN was_VBD detected_VBN in_RB extracts_VBZ made_VBN from_IN these_DT transgenic_JJ lines_NNS ,_, whereas_IN the_DT specific_JJ 55-kDa_NP band_NN appeared_VBD for_IN the_DT L1_JJ protein_NN purified_VBN from_IN insect_NN cell_NN which_WDT was_VBD loaded_VBN as_IN a_DT control_NN (_( data_NNS not_RB shown_VBN )_) ._SENT To_TO confirm_VB the_DT presence_NN of_IN L1p-specific_JJ transcripts_NNS ,_, RNA_NP of_IN the_DT transgenic_JJ lines_NNS was_VBD isolated_VBN and_CC analyzed_VBN by_IN Northern_NP blotting_VBG ._SENT No_DT distinct_JJ L1p-specific_JJ signal_NN was_VBD obtained_VBN for_IN any_DT of_IN the_DT transgenic_JJ lines_NNS investigated_VBD ._SENT However_RB ,_, in_IN some_DT cases_NNS putative_JJ degradation_NN products_NNS of_IN the_DT L1_NP messenger_NN RNAs_NP became_VBD apparent_JJ ._SENT Hybridizing_VBG the_DT same_JJ membrane_NN with_IN a_DT probe_NN for_IN the_DT small_JJ subunit_NN of_IN Rubisco_NP (_( rbcS_NP )_) revealed_VBD similar_JJ transcript_NN abundance_NN in_IN each_DT lane_JJ (_( data_NNS not_RB shown_VBN )_) ._SENT These_DT data_NNS indicate_VBP that_IN L1p_NP mRNA_NP might_MD be_VB unstable_JJ in_IN the_DT transgenic_JJ plants_NNS ._SENT Recently_RB ,_, our_PP$ laboratory_NN described_VBD a_DT humanized_VBN HPV-16_NP L1_NP gene_NN (_( L1h_NP ;_: EMBL_NP database_NN AJ313179_NP )_) that_WDT produces_VBZ at_IN least_JJS 100-_CD and_CC 10,000-fold_NN the_DT amount_NN of_IN L1_JJ protein_NN in_IN mammalian_JJ cells_NNS when_WRB compared_VBN to_TO the_DT L1p_NP and_CC the_DT L1ori_NP gene_NN ,_, respectively_RB ._SENT Since_IN L1_JJ expression_NN was_VBD not_RB achieved_VBN in_IN transgenic_JJ plants_NNS using_VBG either_CC the_DT L1ori_NP or_CC the_DT L1p_NP construct_NN ,_, the_DT L1h_NP gene_NN was_VBD introduced_VBN into_IN tobacco_NN plants_NNS ._SENT A_DT total_NN of_IN 75_CD transgenic_JJ tobacco_NN plants_NNS were_VBD regenerated_VBN and_CC screened_VBN for_IN L1_JJ protein_NN accumulation_NN by_IN immunodetection_NN ._SENT The_DT L1_NP protein_NN was_VBD recognized_VBN by_IN the_DT antibody_NN in_IN some_DT transgenic_JJ lines_NNS as_IN shown_VBN in_IN Fig._NN ,_, although_IN an_DT L1-specific_JJ signal_NN was_VBD observed_VBN only_RB after_IN extended_JJ exposure_NN leading_VBG to_TO a_DT high_JJ background_NN and_CC the_DT amount_NN of_IN protein_NN was_VBD less_JJR than_IN 0.01_CD %_NN of_IN total_JJ soluble_JJ protein_NN ._SENT Northern_JJ blot_NN analysis_NN performed_VBN with_IN selected_JJ lines_NNS showed_VBD that_IN the_DT bulk_NN of_IN L1-transcript_NN ,_, although_IN clearly_RB detectable_JJ ,_, was_VBD degraded_VBN in_IN the_DT L1h-transgenic_JJ tobacco_NN plants_NNS ._SENT Integrity_NN of_IN the_DT isolated_JJ mRNA_NN was_VBD again_RB confirmed_VBN by_IN hybridization_NN of_IN the_DT membrane_NN with_IN the_DT rbcS_NNS probe_NN ._SENT One_CD reason_NN for_IN the_DT low_JJ levels_NNS of_IN L1_JJ protein_NN obtained_VBN in_IN L1h-transgenic_JJ plants_NNS could_MD be_VB that_IN the_DT L1_NP transcripts_NNS had_VBD been_VBN poorly_RB recognized_VBN by_IN the_DT cellular_JJ translation_NN machinery_NN ,_, and_CC thus_RB the_DT transcripts_NNS were_VBD degraded_VBN ._SENT To_TO improve_VB protein_NN translation_NN of_IN the_DT L1h_NP transcripts_NNS ,_, the_DT translational_JJ enhancer_NN Omega_NP of_IN the_DT tobacco_NN mosaic_NN virus_NN (_( U1_NP )_) was_VBD cloned_VBN upstream_RB of_IN the_DT L1_JJ initiation_NN codon_NN (_( OD-L1h_NP )_) ._SENT Due_JJ to_TO the_DT cloning_VBG strategy_NN employed_VBN ,_, the_DT second_JJ amino_NN acid_NN of_IN L1_NP was_VBD altered_VBN from_IN a_DT serine_NN into_IN an_DT alanine_NN ._SENT It_PP is_VBZ unlikely_JJ that_IN this_DT mutation_NN influences_VBZ the_DT ability_NN of_IN L1_NP to_TO assemble_VB into_IN capsomeres_NNS or_CC VLPs_NNS since_IN a_DT number_NN of_IN different_JJ papillomavirus_NN types_NNS (_( e.g._FW ,_, HPV-1_NP ,_, -18_CD ,_, -30_CD ,_, and_CC -45_CD and_CC bovine_JJ papillomavirus_NN types_NNS 1_CD and_CC 2_CD )_) do_VBP contain_VB an_DT alanine_NN at_IN position_NN 2_CD of_IN their_PP$ L1_JJ sequence_NN ._SENT Using_VBG the_DT OD-L1h_NP expression_NN construct_NN ,_, 88_CD transgenic_JJ tobacco_NN lines_NNS were_VBD obtained_VBN ._SENT In_IN addition_NN ,_, about_RB 80_CD transgenic_JJ lines_NNS harboring_VBG the_DT L1p_NP gene_NN fused_VBD to_TO the_DT TMV_NP translational_JJ enhancer_NN were_VBD regenerated_VBN (_( OD-L1p_NP )_) ._SENT Transgenic_NP lines_NNS were_VBD again_RB screened_VBN by_IN Western_NP blotting_VBG ._SENT While_IN no_DT L1_NP protein_NN was_VBD detectable_JJ in_IN the_DT OD-L1p_NP lines_NNS (_( data_NNS not_RB shown_VBN )_) ,_, significant_JJ amounts_NNS of_IN L1_JJ protein_NN accumulated_VBN in_IN several_JJ of_IN the_DT OD-L1h_NP expressing_VBG plants_NNS ._SENT Ten_CD highly_RB expressing_VBG lines_NNS were_VBD selected_VBN and_CC transferred_VBN to_TO the_DT greenhouse_NN ._SENT These_DT tobacco_NN lines_NNS did_VBD not_RB show_VB any_DT phenotypic_JJ alterations_NNS ._SENT As_IN shown_VBN in_IN Fig._NN ,_, L1h_NP mRNA_NP is_VBZ highly_RB abundant_JJ in_IN these_DT lines_NNS ._SENT Apparently_RB ,_, protein_NN accumulation_NN was_VBD also_RB improved_VBN by_IN introduction_NN of_IN TMV_NP overdrive_NN Omega_NP sequence_NN as_RB indicated_VBD by_IN strong_JJ signals_NNS in_IN Western_JJ blots_NNS ._SENT The_DT percentage_NN of_IN L1_JJ protein_NN as_IN fraction_NN of_IN total_JJ soluble_JJ protein_NN was_VBD estimated_VBN to_TO be_VB approximately_RB 0.5_CD %_NN ._SENT This_DT calculation_NN is_VBZ based_VBN on_IN comparison_NN with_IN the_DT amount_NN of_IN insect_NN cell-derived_NN purified_VBD L1_JJ protein_NN (_( 80_CD ng_NNS )_) which_WDT was_VBD loaded_VBN on_IN the_DT gel_NN as_IN a_DT control_NN ._SENT In_IN order_NN to_TO demonstrate_VB that_DT expression_NN of_IN the_DT optimized_VBN OD-L1h_NP construct_NN is_VBZ not_RB restricted_VBN to_TO tobacco_NN plants_NNS and_CC to_TO produce_VB L1_NP in_IN a_DT plant_NN species_NNS more_RBR suitable_JJ for_IN feeding_VBG experiments_NNS ,_, the_DT construct_NN was_VBD also_RB introduced_VBN into_IN potato_NN plants_NNS ._SENT Immunodetection_NP revealed_VBD the_DT presence_NN of_IN the_DT L1_JJ protein_NN in_IN potato_NN tubers_NNS in_IN 15_CD out_RB of_IN 48_CD transgenic_JJ lines_NNS in_IN similar_JJ quantities_NNS as_IN in_IN leaves_NNS of_IN the_DT transgenic_JJ tobacco_NN plants_NNS ._SENT We_PP estimated_VBD that_IN L1_JJ accounts_NNS for_IN about_RB 0.2_CD %_NN of_IN total_JJ soluble_JJ tuber_NN protein_NN ._SENT In_IN general_NN ,_, the_DT size_NN of_IN the_DT L1_JJ protein_NN extracted_VBN from_IN either_DT tobacco_NN or_CC potato_NN was_VBD indistinguishable_JJ from_IN that_DT of_IN the_DT L1_NP purified_VBD from_IN insect_NN cells_NNS ,_, indicating_VBG that_IN no_DT significant_JJ modification_NN such_JJ as_IN glycosylation_NN had_VBD occurred_VBN ._SENT Purification_NN of_IN HPV-16_NP L1_NP VLPs_NP from_IN transgenic_JJ plants_NNS ._SENT |_SYM After_IN L1_JJ expression_NN was_VBD observed_VBN in_IN transgenic_JJ plants_NNS ,_, we_PP wished_VBD to_TO determine_VB whether_IN the_DT L1_NP protein_NN assembles_VBZ into_IN viral_JJ pentameres_NNS (_( capsomeres_NNS )_) and_CC forms_NNS VLPs_NNS ._SENT Both_DT states_NNS of_IN virion_NN assembly_NN can_MD be_VB distinguished_VBN from_IN the_DT L1_JJ monomer_NN by_IN the_DT presence_NN of_IN conformation-specific_JJ epitopes_NNS ,_, their_PP$ sedimentation_NN coefficient_NN in_IN sucrose_NN gradients_NNS ,_, and_CC their_PP$ buoyant_JJ density_NN ._SENT Plant_NN tissues_NNS were_VBD extracted_VBN using_VBG a_DT modified_JJ protocol_NN which_WDT was_VBD originally_RB established_VBN for_IN the_DT purification_NN of_IN HPV_NP VLPs_NP expressed_VBD in_IN insect_NN cells_NNS ._SENT Cleared_VBN plant_NN extracts_VBZ were_VBD sedimented_VBN through_IN a_DT sucrose_NN cushion_NN followed_VBN by_IN a_DT CsCl_NP equilibrium_NN density_NN centrifugation_NN as_IN described_VBN in_IN Materials_NPS and_CC Methods_NP ._SENT The_DT L1_NP protein_NN was_VBD detected_VBN using_VBG an_DT antigen-capture_NN ELISA_NN which_WDT is_VBZ specific_JJ for_IN conformational_JJ epitopes_NNS presented_VBN on_IN the_DT surface_NN of_IN viral_JJ capsomeres_NNS and_CC capsids_NNS ._SENT Most_JJS of_IN the_DT L1-antigen_NP concentrated_VBD at_IN a_DT density_NN of_IN 1.32_CD g/ml_NN in_IN the_DT CsCl_NP gradients_NNS ._SENT These_DT results_NNS show_VBP that_IN conformation-specific_JJ epitopes_NNS were_VBD displayed_VBN ._SENT Therefore_RB plant-derived_VBN L1_NP apparently_RB assembled_VBD into_IN viral_JJ capsomeres_NNS and_CC most_RBS likely_RB formed_VBN VLPs_NP ._SENT Peak_NN fractions_NNS of_IN CsCl_NP gradients_NNS were_VBD analyzed_VBN by_IN electron_NN microscopy_NN to_TO determine_VB whether_IN VLPs_NP were_VBD indeed_RB formed_VBN in_IN OD-L1h_NP potato_NN plants_NNS ._SENT Thereby_RB ,_, we_PP were_VBD able_JJ to_TO visualize_VB VLPs_NNS in_IN fractions_NNS with_IN a_DT buoyant_JJ density_NN of_IN 1.32_CD g/ml_NN ._SENT To_TO determine_VB the_DT amount_NN of_IN L1_JJ protein_NN that_WDT is_VBZ in_IN an_DT assembled_VBN form_NN ,_, crude_NN extracts_VBZ of_IN tobacco_NN leaves_NNS and_CC potato_NN tubers_NNS were_VBD fractionated_VBN by_IN sucrose_NN density_NN gradient_JJ centrifugation_NN ._SENT This_DT analysis_NN allows_VBZ quantitative_JJ separation_NN of_IN L1_JJ monomers_NNS ,_, pentamers_NNS ,_, and_CC higher_JJR assembly_NN forms_NNS such_JJ as_IN VLPs_NP ._SENT The_DT extracts_VBZ were_VBD loaded_VBN onto_IN linear_JJ sucrose_NN gradients_NNS (_( 5_CD to_TO 50_CD %_NN )_) and_CC centrifuged_VBN at_IN 160,000_CD x_NN g_NN for_IN 3.5_CD h_NN where_WRB after_IN 20_CD fractions_NNS were_VBD collected_VBN (_( fraction_NN 1_CD bottom_NN of_IN the_DT tube_NN )_) and_CC L1_NP protein_NN was_VBD detected_VBN by_IN ELISA_NP ._SENT Under_IN these_DT conditions_NNS ,_, insect_NN cell-derived_JJ VLPs_NNS are_VBP found_VBN in_IN fractions_NNS 3_CD to_TO 6_CD (_( approximately_RB 120S_JJ )_) ._SENT Treatment_NN of_IN VLPs_NP leads_VBZ to_TO disassembly_NN into_IN capsomeres_NNS with_IN a_DT lower_JJR sedimentation_NN coefficient_NN ,_, which_WDT are_VBP concentrated_VBN in_IN fractions_NNS 16_CD to_TO 18_CD (_( data_NNS not_RB shown_VBN )_) ._SENT No_DT signal_NN was_VBD obtained_VBN when_WRB extracts_VBZ of_IN tubers_NNS from_IN nontransgenic_JJ plants_NNS were_VBD analyzed_VBN ._SENT When_WRB extracts_VBZ of_IN tobacco_NN leaves_NNS were_VBD analyzed_VBN ,_, two_CD peaks_NNS of_IN the_DT L1_NP protein_NN were_VBD observed_VBN ,_, a_DT smaller_JJR peak_NN in_IN fractions_NNS 16_CD and_CC 17_CD ,_, consistent_JJ with_IN the_DT sedimentation_NN pattern_NN of_IN capsomeres_NNS and_CC a_DT larger_JJR peak_NN in_IN the_DT fractions_NNS 9_CD and_CC 10_CD ._SENT Using_VBG empty_JJ VLPs_NNS of_IN adeno-associated_JJ viruses_NNS as_IN sedimentation_NN markers_NNS (_( 60S_JJ )_) we_PP estimated_VBD the_DT sedimentation_NN coefficient_NN of_IN the_DT L1_JJ assembly_NN forms_NNS present_JJ in_IN fractions_NNS 9_CD and_CC 10_CD to_TO be_VB approximately_RB 60_CD to_TO 70S_NNS ._SENT When_WRB extracts_VBZ of_IN L1-expressing_NP potato_NN tubers_NNS were_VBD analyzed_VBN ,_, we_PP again_RB found_VBD a_DT major_JJ peak_NN of_IN L1_NP at_IN 70S_NP ._SENT Extracts_VBZ of_IN some_DT transgenic_JJ lines_NNS gave_VBD rise_NN to_TO the_DT capsomere_NN peak_NN while_NN extracts_VBZ from_IN other_JJ lines_NNS did_VBD not_RB and_CC it_PP remains_VBZ to_TO be_VB determined_VBN ,_, whether_IN this_DT observation_NN is_VBZ specific_JJ for_IN the_DT respective_JJ transgenic_JJ lines_NNS ._SENT Only_JJ small_JJ amounts_NNS of_IN L1_JJ protein_NN were_VBD detected_VBN in_IN fractions_NNS corresponding_JJ to_TO intact_JJ VLPs_NNS ._SENT From_IN the_DT amount_NN of_IN insect_NN cell-derived_JJ VLPs_NNS loaded_VBN onto_IN the_DT gradient_NN ,_, we_PP projected_VBD that_IN the_DT peak_NN fractions_NNS represent_VBP approximately_RB 3_CD to_TO 5_CD mug_NN of_IN L1_JJ protein_NN from_IN approximately_RB 0,35_CD g_NN of_IN leave_NN or_CC tuber_NN material_NN ._SENT Immunogenicity_NN of_IN plant-derived_JJ HPV-16_NP L1_NP VLPs_NP ._SENT |_SYM To_TO analyze_VB whether_IN the_DT plant_NN that_WDT produced_VBD L1_NP is_VBZ able_JJ to_TO induce_VB a_DT humoral_JJ immune_JJ response_NN ,_, groups_NNS of_IN six_CD mice_NNS were_VBD either_RB immunized_VBN with_IN a_DT low_JJ dose_NN of_IN VLPs_NNS purified_VBN from_IN plants_NNS (_( 40_CD ng_NNS of_IN VLPs_NP per_IN mouse_NN )_) or_CC with_IN the_DT same_JJ amount_NN of_IN insect_NN cell-derived_JJ VLPs_NP ._SENT Generation_NN of_IN capsid-specific_JJ anti-L1_JJ antibodies_NNS was_VBD measured_VBN by_IN ELISA_NP using_VBG insect_NN cell-derived_JJ VLPs_NNS as_IN antigen_NN ._SENT Results_NNS show_VBP that_IN VLPs_NP formed_VBD in_IN plants_NNS were_VBD as_RB immunogenic_JJ as_IN VLPs_NP produced_VBD in_IN insect_NN cells_NNS ._SENT While_IN sera_NN of_IN all_DT mice_NNS immunized_VBN with_IN plant-derived_JJ VLPs_NNS responded_VBD in_IN the_DT ELISA_NP ,_, only_RB five_CD out_IN of_IN the_DT six_CD mice_NNS immunized_VBN with_IN insect_NN cell-derived_JJ VLPs_NP gave_VBD a_DT positive_JJ signal_NN ._SENT No_DT differences_NNS in_IN titers_NNS were_VBD observed_VBN comparing_VBG the_DT two_CD groups_NNS of_IN mice_NNS ._SENT Immunogenicity_NN of_IN transgenic_JJ plants_NNS after_IN oral_JJ ingestion_NN ._SENT |_SYM To_TO determine_VB whether_IN L1_JJ transgenic_JJ plants_NNS can_MD be_VB used_VBN as_IN edible_JJ vaccine_NN ,_, L1-positive_JJ potato_NN tubers_NNS were_VBD fed_VBN to_TO C57/BL6_NP mice_NNS ._SENT Thirty_CD mice_NNS falling_VBG into_IN five_CD different_JJ groups_NNS were_VBD fed_VBN four_CD times_NNS for_IN 20_CD h_NN at_IN an_DT interval_NN of_IN approximately_RB 15_CD days_NNS with_IN tubers_NNS from_IN transgenic_JJ and_CC nontransgenic_JJ potatoes_NNS ._SENT Groups_NNS 1_CD to_TO 3_CD (_( mice_NNS 1_CD to_TO 8_CD ,_, 9_CD to_TO 17_CD ,_, and_CC 18_CD to_TO 24_CD )_) received_VBD L1_JJ tubers_NNS from_IN transgenic_JJ plants_NNS ;_: groups_NNS 4_CD and_CC 5_CD (_( mice_NNS 25_CD to_TO 27_CD and_CC 28_CD to_TO 30_CD )_) received_VBD tubers_NNS from_IN nontransgenic_JJ plants_NNS ._SENT In_IN three_CD groups_NNS ,_, cholera_NN toxin_NN B-peptide_NP (_( group_NN 2_CD )_) and_CC CpG_NP plasmid_NP DNA_NP (_( groups_NNS 3_CD and_CC 5_CD )_) were_VBD added_VBN onto_IN the_DT tubers_NNS as_IN adjuvants_NNS in_IN all_PDT the_DT feedings_NNS ._SENT Sera_NN from_IN mice_NNS were_VBD collected_VBN before_IN the_DT first_JJ and_CC 2_CD to_TO 3_CD weeks_NNS after_IN each_DT feeding_NN (_( see_VB Materials_NNS and_CC Methods_NNS )_) and_CC tested_VBN in_IN an_DT ELISA_NP for_IN the_DT presence_NN of_IN L1-specific_JJ antibodies_NNS ._SENT Results_NNS indicated_VBD that_IN all_DT sera_NN from_IN mice_NNS of_IN the_DT control_NN groups_NNS (_( groups_NNS 4_CD and_CC 5_CD )_) remained_VBD negative_JJ throughout_IN the_DT feeding_NN ._SENT After_IN the_DT third_JJ feeding_NN ,_, three_CD mice_NNS of_IN the_DT groups_NNS (_( one_CD in_IN group_NN 2_CD and_CC two_CD mice_NNS in_IN group_NN 3_CD )_) fed_NN with_IN transgenic_JJ material_NN showed_VBD an_DT L1-specific_JJ response_NN ._SENT After_IN the_DT fourth_JJ feeding_NN ,_, this_DT response_NN was_VBD no_RB longer_RBR detectable_JJ in_IN two_CD of_IN the_DT three_CD mice_NNS while_IN it_PP was_VBD increased_VBN in_IN one_CD mouse_NN of_IN group_NN 3_CD ._SENT Sera_NN of_IN four_CD mice_NNS of_IN group_NN 1_CD also_RB showed_VBD an_DT elevated_JJ reaction_NN in_IN the_DT ELISA_NP ,_, but_CC this_DT was_VBD rather_RB weak_JJ and_CC not_RB significantly_RB different_JJ from_IN the_DT control_NN group_NN ._SENT Since_IN only_RB weak_JJ and_CC mostly_RB transiently_RB anti-L1_JJ antibody_NN responses_NNS were_VBD detected_VBN after_IN oral_JJ vaccination_NN in_IN all_DT but_CC three_CD sera_NN ,_, we_PP wished_VBD to_TO determine_VB whether_IN there_EX was_VBD a_DT priming_NN of_IN a_DT humoral_JJ response_NN by_IN the_DT feeding_NN of_IN L1-containing_NP tubers_NNS ._SENT Therefore_RB ,_, all_DT remaining_VBG 27_CD mice_NNS were_VBD injected_VBN with_IN a_DT subimmunogenic_JJ dose_NN of_IN purified_VBN VLPs_NNS (_( 20_CD ng_NNS )_) ._SENT In_IN a_DT separate_JJ experiment_NN ,_, we_PP determined_VBD that_IN a_DT minimum_NN of_IN approximately_RB 800_CD ng_NNS of_IN purified_VBN VLPs_NNS in_IN a_DT single_JJ injection_NN was_VBD required_VBN to_TO mount_VB a_DT significant_JJ anti-L1_JJ response_NN in_IN mice_NNS when_WRB injections_NNS were_VBD administered_VBN s.c._JJ Two_NP weeks_NNS after_IN receiving_VBG the_DT subimmunogenic_JJ dose_NN ,_, all_DT mice_NNS were_VBD sacrificed_VBN and_CC sera_NN were_VBD tested_VBN for_IN the_DT presence_NN of_IN L1-specific_JJ antibodies_NNS by_IN ELISA_NP ._SENT About_IN half_NN of_IN the_DT mice_NNS (_( 11_CD of_IN 21_CD )_) that_WDT had_VBD been_VBN fed_VBN with_IN tubers_NNS from_IN transgenic_JJ plants_NNS but_CC none_NN of_IN the_DT control_NN mice_NNS developed_VBD L1-specific_JJ antibodies_NNS after_IN receiving_VBG the_DT subimmunogenic_JJ dose_NN ,_, indicating_VBG that_IN oral_JJ ingestion_NN of_IN L1-positive_JJ tubers_NNS had_VBD primed_VBN a_DT humoral_JJ response_NN against_IN the_DT L1_JJ protein_NN ._SENT We_PP developed_VBD transgenic_JJ tobacco_NN and_CC potato_NN plants_NNS expressing_VBG the_DT HPV-16_NP major_JJ structural_JJ protein_NN L1_NP by_IN changing_VBG the_DT L1_JJ gene_NN codon_NN usage_NN and_CC increasing_VBG its_PP$ transcript_NN stability_NN ._SENT Infections_NNS with_IN HPV_NP are_VBP causatively_RB related_VBN to_TO the_DT development_NN of_IN cervical_JJ cancer_NN ._SENT For_IN this_DT reason_NN ,_, efforts_NNS are_VBP under_IN way_NN to_TO develop_VB prophylactic_JJ vaccines_NNS that_WDT prevent_VBP primary_JJ infection_NN with_IN the_DT virus_NN ._SENT Prophylactic_JJ vaccination_NN against_IN HPV_NP could_MD prevent_VB the_DT development_NN of_IN almost_RB half_PDT a_DT million_CD of_IN cancer_NN cases_NNS every_DT year_NN ._SENT Prime_JJ candidate_NN for_IN the_DT production_NN of_IN prophylactic_JJ vaccine_NN is_VBZ the_DT papillomavirus_NN major_JJ structural_JJ protein_NN L1_NP in_IN the_DT form_NN of_IN VLPs_NP or_CC viral_JJ capsomeres_NNS (_( pentamers_NNS )_) ._SENT Both_CC assembly_NN forms_NNS have_VBP been_VBN demonstrated_VBN to_TO induce_VB long_JJ lasting_JJ protective_JJ immune_JJ responses_NNS in_IN animal_JJ models_NNS ._SENT Currently_RB ,_, VLP-based_JJ vaccines_NNS are_VBP under_IN clinical_JJ evaluation_NN ,_, and_CC a_DT licensed_JJ product_NN can_MD be_VB expected_VBN in_IN the_DT coming_VBG years_NNS ._SENT High_JJ costs_NNS for_IN production_NN and_CC distribution_NN ,_, however_RB ,_, will_MD not_RB immediately_RB allow_VB widespread_JJ application_NN of_IN a_DT papillomavirus_NN vaccine_NN that_WDT is_VBZ based_VBN on_IN recombinant_JJ VLPs_NNS ._SENT One_CD of_IN the_DT alternatives_NNS might_MD be_VB the_DT production_NN of_IN VLPs_NNS or_CC capsomeres_NNS using_VBG L1-transgenic_JJ plants_NNS ._SENT These_DT plants_NNS could_MD be_VB either_RB used_VBN as_IN bioreactors_NNS for_IN VLP_NP production_NN or_CC as_IN edible_JJ vaccines_NNS ._SENT Two_CD reasons_NNS allow_VBP one_PP to_TO argue_VB that_DT production_NN of_IN an_DT edible_JJ plant-derived_JJ papillomavirus_NN vaccine_NN is_VBZ feasible_JJ ._SENT First_RB ,_, a_DT number_NN of_IN different_JJ antigens_NNS was_VBD already_RB produced_VBN in_IN plants_NNS and_CC their_PP$ oral_JJ delivery_NN led_VBN to_TO the_DT induction_NN of_IN a_DT protective_JJ immune_JJ response_NN (_( summarized_VBN in_IN reference_NN )_) ._SENT Secondly_RB ,_, it_PP has_VBZ been_VBN demonstrated_VBN that_IN papillomavirus_NN capsid_NN antigens_NNS are_VBP immunogenic_JJ when_WRB delivered_VBN orally_RB ,_, most_RBS likely_JJ because_IN they_PP are_VBP recognized_VBN by_IN the_DT immune_JJ system_NN due_JJ to_TO their_PP$ virus-like_JJ structure_NN ._SENT While_IN the_DT majority_NN of_IN antigens_NNS in_IN the_DT intestine_NN are_VBP ignored_VBN by_IN the_DT immune_JJ system_NN ,_, M_NP cells_NNS located_VBN in_IN the_DT Peyer_NP 's_POS patches_VBZ selectively_RB take_VB up_RP particulate_JJ antigens_NNS such_JJ as_IN virus_NN particles_NNS and_CC transport_VB them_PP from_IN the_DT intestine_NN to_TO underlying_VBG follicles_NNS ._SENT The_DT activation_NN of_IN a_DT mucosal_JJ immune_JJ response_NN leads_VBZ to_TO the_DT production_NN of_IN secretory_JJ immunoglobulin_NN A_NP (_( IgA_NP )_) antibodies_NNS but_CC also_RB to_TO serum_NN IgG_NP antibodies_NNS ._SENT A_DT putative_JJ prerequisite_NN for_IN the_DT induction_NN of_IN a_DT mucosal_JJ immune_JJ response_NN against_IN viral_JJ capsid_NN antigens_NNS by_IN edible_JJ vaccines_NNS ,_, however_RB ,_, is_VBZ that_IN the_DT proteins_NNS are_VBP presented_VBN to_TO the_DT M_NP cells_NNS in_IN a_DT particulate_JJ state_NN ._SENT This_DT requires_VBZ that_IN the_DT capsid_NN proteins_NNS be_VB able_JJ to_TO assemble_VB into_IN VLPs_NNS or_CC capsomeres_NNS within_IN the_DT transgenic_JJ plants_NNS and_CC that_IN upon_IN ingestion_NN and_CC passage_NN through_IN the_DT low_JJ pH_NN of_IN the_DT stomach_NN ,_, these_DT particles_NNS remain_VBP intact_JJ ._SENT In_IN general_JJ ,_, it_PP can_MD be_VB expected_VBN that_IN the_DT sturdy_JJ plant_NN cell_NN walls_NNS provide_VBP a_DT protective_JJ environment_NN for_IN the_DT expressed_VBN antigens_NNS ._SENT In_IN addition_NN ,_, it_PP has_VBZ been_VBN recently_RB demonstrated_VBN that_IN the_DT papillomavirus_NN capsid_NN antigens_NNS remain_VBP immunogenic_JJ after_IN exposure_NN to_TO low_JJ pH_NN through_IN oral_JJ delivery_NN ._SENT To_TO demonstrate_VB that_IN L1_NP assembles_VBZ into_IN VLPs_NP in_IN the_DT transgenic_JJ plants_NNS generated_VBN in_IN this_DT study_NN ,_, VLPs_NP were_VBD purified_VBN and_CC enriched_VBN by_IN sedimentation_NN and_CC equilibrium_NN centrifugation_NN ._SENT The_DT plant-derived_JJ L1_JJ antigen_NN accumulated_VBN at_IN a_DT density_NN of_IN 1.32_CD g/ml_NN ,_, which_WDT is_VBZ consistent_JJ with_IN the_DT presence_NN of_IN VLPs_NNS or_CC capsomeres_NNS ._SENT Electron_NP microscopy_NN confirmed_VBD the_DT presence_NN of_IN VLPs_NP in_IN the_DT CsCl_NP fractions_NNS ,_, although_IN the_DT yield_NN was_VBD relatively_RB low_JJ ._SENT Sucrose_NN sedimentation_NN analysis_NN of_IN soluble_JJ proteins_NNS derived_VBN from_IN crude_NN extracts_VBZ of_IN leaves_NNS and_CC tubers_NNS revealed_VBD that_IN a_DT significant_JJ portion_NN of_IN the_DT L1_JJ antigen_NN is_VBZ in_IN the_DT form_NN of_IN viral_JJ capsomeres_NNS but_CC also_RB of_IN higher-order_JJ structures_NNS with_IN a_DT lower_JJR sedimentation_NN coefficient_NN compared_VBN to_TO intact_JJ VLPs_NNS and_CC which_WDT are_VBP not_RB easily_RB detectable_JJ by_IN electron_NN microscopy_NN ._SENT The_DT reason_NN for_IN preferential_JJ formation_NN of_IN these_DT structures_NNS compared_VBN to_TO VLPs_NP needs_VBZ to_TO be_VB further_RBR investigated_VBN ._SENT From_IN our_PP$ observation_NN in_IN a_DT mammalian_JJ expression_NN system_NN ,_, we_PP believe_VBP that_IN relatively_RB high_JJ concentrations_NNS of_IN L1_JJ protein_NN are_VBP required_VBN for_IN formation_NN of_IN VLP_NP structures_NNS ._SENT Under_IN such_JJ conditions_NNS ,_, the_DT same_JJ L1_JJ open_JJ reading_NN frame_NN used_VBN to_TO generate_VB the_DT transgenic_JJ plants_NNS leads_VBZ to_TO the_DT formation_NN of_IN capsomeres_NNS ,_, intact_JJ VLPs_NNS as_RB well_RB as_IN smaller_JJR quantities_NNS of_IN the_DT 60_CD to_TO 70S_NP assembly_NN forms_NNS ,_, which_WDT might_MD represent_VB assembly_NN intermediates_NNS or_CC assembly_NN by-products_NNS (_( unpublished_JJ observations_NNS )_) ._SENT Subcellular_JJ localization_NN analysis_NN studies_NNS in_IN a_DT transient_JJ viral_JJ plant_NN expression_NN system_NN suggest_VBP that_IN the_DT L1_JJ protein_NN fails_VBZ to_TO enter_VB the_DT n_NN 